Comparing 150 IU and 225 IU of recombinant FSH in predicted normal responders undergoing GnRH antagonist stimulatio n in IVF/ICSI: a randomised controlled trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061018

Enrollment

Unknown

Registered

2022-06-15

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

A:rFSH started with 150 IU/day

B:rFSH started with225 IU/day

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Women age 1.11ng/ml, FSH < 10IU/L; 3. BMI = 18-25 kg/m2; 4. Infertile couples scheduled for their first IVF/ICSI cycle; 5. Women who will treated with gonadotrophin-releasing hormone (GnRH) antagonist protocol COH; 6. Informed consent obtained.

Exclusion criteria

Exclusion criteria: 1.Women with sever uterine anomaly or severe hydrosalpinx, moderate or severe endometriosis or history of recurrent miscarriage; 2. Couples undergoing PGD and PGS; 3. Women with contraindication for pregnancy, such as severe endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney).

Design outcomes

Primary

Measure	Time frame
Live-birth rate;	—

Countries

China

Contacts

Public ContactHe Cai

caihe@bjmu.edu.cn+86 13581613908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026